Claim Your Share: Potential Settlement for Prescription Generic Drug Payments#USA#Philadelphia#Generic_Drugs#Lawsuit_Settlement#Consumer_Rights
Claim Your Share: Potential Settlement for Prescription Generic Drug Payments
If you paid for specific prescription generics in the U.S. from May 1, 2009, to December 31, 2019, you may be eligible to file a claim for settlement compensation.
third-news.com
July 10, 2026 at 9:09 PM
Claim Your Share: Potential Settlement for Prescription Generic Drug Payments#USA#Philadelphia#Generic_Drugs#Lawsuit_Settlement#Consumer_Rights
Collective Settlement Announced for Prescription Drug Payments Between 2009 and 2019#USA#Philadelphia#Settlement#Generic_Drugs#Prescription
Collective Settlement Announced for Prescription Drug Payments Between 2009 and 2019
Individuals who paid for specific prescription generic drugs in the U.S. from 2009 to 2019 may qualify for a share of a $533 million settlement.
third-news.com
July 10, 2026 at 9:10 PM
Collective Settlement Announced for Prescription Drug Payments Between 2009 and 2019#USA#Philadelphia#Settlement#Generic_Drugs#Prescription
Examining the Quality of Generic Drugs as Patents Expire for Major Medications#United_States#Los_Angeles#Generic_Drugs#Wisner_Baum#Behram_Parekh
Examining the Quality of Generic Drugs as Patents Expire for Major Medications
As major drugs lose patent protection, concerns rise about the quality and efficacy of generic alternatives. Legal expert Behram Parekh cautions against prioritizing cost over safety.
third-news.com
September 22, 2026 at 12:40 PM
Examining the Quality of Generic Drugs as Patents Expire for Major Medications#United_States#Los_Angeles#Generic_Drugs#Wisner_Baum#Behram_Parekh
Settlement Announced for Consumers Who Bought Generic Prescription Drugs in the U.S.#United_States#Hartford#Generic_Drugs#Settlements#Glenmark_Pharmaceuticals
Settlement Announced for Consumers Who Bought Generic Prescription Drugs in the U.S.
A recent settlement affects consumers who overpaid for certain generic prescription drugs due to alleged price fixing. Key details inside.
third-news.com
August 24, 2026 at 12:16 PM
Settlement Announced for Consumers Who Bought Generic Prescription Drugs in the U.S.#United_States#Hartford#Generic_Drugs#Settlements#Glenmark_Pharmaceuticals
Connecticut Attorney General Reaches Settlement with Generic Drug Manufacturers Over Price Fixing#United_States#Hartford#Connecticut#Generic_Drugs#Glenmark_Pharmaceuticals
Connecticut Attorney General Reaches Settlement with Generic Drug Manufacturers Over Price Fixing
A significant legal settlement has been reached concerning generic prescription drugs, offering consumers potential compensation for overcharges.
third-news.com
August 24, 2026 at 12:14 PM
Connecticut Attorney General Reaches Settlement with Generic Drug Manufacturers Over Price Fixing#United_States#Hartford#Connecticut#Generic_Drugs#Glenmark_Pharmaceuticals
Consumers of Certain Generic Medications in America Could Benefit from Settlement Payments#Generic_Drugs#Glenmark_Pharmaceuticals#Settlement_Fund
Consumers of Certain Generic Medications in America Could Benefit from Settlement Payments
The Connecticut Attorney General's office announced a new settlement that could provide compensation to consumers who purchased overpriced generic medications in the U.S.
third-news.com
August 24, 2026 at 12:13 PM
Consumers of Certain Generic Medications in America Could Benefit from Settlement Payments#Generic_Drugs#Glenmark_Pharmaceuticals#Settlement_Fund
Connecticut Attorney General's Settlement with Generic Drug Manufacturers Provides Relief to Consumers#USA#Hartford#Generic_Drugs#Glenmark_Pharmaceuticals#Drug_Settlement
Connecticut Attorney General's Settlement with Generic Drug Manufacturers Provides Relief to Consumers
Connecticut's Attorney General announces a settlement with Glenmark Pharmaceuticals over inflated drug prices, aiding consumers who purchased eligible generic medications.
third-news.com
August 24, 2026 at 12:19 PM
Connecticut Attorney General's Settlement with Generic Drug Manufacturers Provides Relief to Consumers#USA#Hartford#Generic_Drugs#Glenmark_Pharmaceuticals#Drug_Settlement
Collective Action Settlement Announced for Generic Drug Refunds in the U.S.#USA#Philadelphia#Generic_Drugs#Class_Action_Settlements#Legal_Notifications
Collective Action Settlement Announced for Generic Drug Refunds in the U.S.
Individuals who paid for certain generic prescription drugs between 2009 and 2019 in the U.S. may claim a share of a $533 million settlement.
third-news.com
July 10, 2026 at 9:10 PM
Collective Action Settlement Announced for Generic Drug Refunds in the U.S.#USA#Philadelphia#Generic_Drugs#Class_Action_Settlements#Legal_Notifications
Most #generic_drugs sold in USA are produced in overseas factories, periodically inspected by our #FDA. Learn about #ProPublica's #RxInspector to find out where your generic drug is made and see inspection reports.
www.propublica.org/podcast/what...
www.propublica.org/podcast/what...
What the FDA Won’t Tell You About Your Medications
For years, the FDA said generics are just as safe as brand-name medications. ProPublica found that this isn’t always true.
www.propublica.org
May 16, 2026 at 8:12 PM
Most #generic_drugs sold in USA are produced in overseas factories, periodically inspected by our #FDA. Learn about #ProPublica's #RxInspector to find out where your generic drug is made and see inspection reports.
www.propublica.org/podcast/what...
www.propublica.org/podcast/what...
Small Molecule API Market Set to Reach $202.53 Billion by 2036, Fueled by Demand for Generic Drugs and Oncology Expansion#United_States#Newark#API_Market#Generic_Drugs#oncology_pipeline
Small Molecule API Market Set to Reach $202.53 Billion by 2036, Fueled by Demand for Generic Drugs and Oncology Expansion
The small molecule API market is projected to expand to $202.53 billion by 2036, driven by a surge in generic drug demand and oncology advancements.
third-news.com
April 28, 2026 at 5:41 PM
Small Molecule API Market Set to Reach $202.53 Billion by 2036, Fueled by Demand for Generic Drugs and Oncology Expansion#United_States#Newark#API_Market#Generic_Drugs#oncology_pipeline
Steady Growth in Global Pharmaceutical Intermediates Market Driven by Rise in Generic Drug Demand and Advanced Manufacturing#None#biotechnology#pharmaceuticals#Generic_Drugs
Steady Growth in Global Pharmaceutical Intermediates Market Driven by Rise in Generic Drug Demand and Advanced Manufacturing
The global pharmaceutical intermediates market is growing steadily, projected to reach USD 57.03 billion by 2035, fueled by demand for generic drugs and advanced manufacturing techniques.
third-news.com
April 23, 2026 at 2:58 PM
Steady Growth in Global Pharmaceutical Intermediates Market Driven by Rise in Generic Drug Demand and Advanced Manufacturing#None#biotechnology#pharmaceuticals#Generic_Drugs
Connecticut Attorney General Announces Settlement for Generic Drug Price-Fixing Claims#Settlement#Connecticut#Generic_Drugs
Connecticut Attorney General Announces Settlement for Generic Drug Price-Fixing Claims
Connecticut's Attorney General reveals new settlements with generic drug manufacturers for illegal price-fixing practices affecting consumers' expenses.
third-news.com
March 17, 2026 at 2:20 PM
Connecticut Attorney General Announces Settlement for Generic Drug Price-Fixing Claims#Settlement#Connecticut#Generic_Drugs
Connecticut Settles with Generic Drug Makers Over Pricing Allegations Impacting Consumers#United_States#Hartford#Generic_Drugs#Bausch_Health#Lannett_Company
Connecticut Settles with Generic Drug Makers Over Pricing Allegations Impacting Consumers
Recent settlements in Connecticut allow consumers who purchased generic drugs to receive payments for overinflated prices. Details outlined.
third-news.com
March 17, 2026 at 1:53 PM
Connecticut Settles with Generic Drug Makers Over Pricing Allegations Impacting Consumers#United_States#Hartford#Generic_Drugs#Bausch_Health#Lannett_Company
Upcoming Commemorative Seminar for Generic Pharmaceuticals Day on December 22, 2023#Japan#Tokyo#pharmaceuticals#Generic_Drugs#GEDA
Upcoming Commemorative Seminar for Generic Pharmaceuticals Day on December 22, 2023
Join us on December 22 for an insightful discussion on the state of generic pharmaceuticals and their impact on healthcare today. Entry is free.
third-news.com
December 15, 2025 at 9:13 AM
Upcoming Commemorative Seminar for Generic Pharmaceuticals Day on December 22, 2023#Japan#Tokyo#pharmaceuticals#Generic_Drugs#GEDA
Global Generic Drugs Market Expected to Reach USD 898 Billion by 2035, Driven by Diverse Growth Factors#USA#New_York#pharmaceuticals#Generic_Drugs#Vantage_Market_Research
Global Generic Drugs Market Expected to Reach USD 898 Billion by 2035, Driven by Diverse Growth Factors
The global generic drugs market is projected to grow from USD 487.21 billion in 2024 to USD 898 billion by 2035. Factors include patent expirations and rising chronic diseases.
third-news.com
November 25, 2025 at 10:08 AM
Global Generic Drugs Market Expected to Reach USD 898 Billion by 2035, Driven by Diverse Growth Factors#USA#New_York#pharmaceuticals#Generic_Drugs#Vantage_Market_Research
Par Health Emerges as Independent Leader in Generic Pharmaceuticals and Sterile Injectables#United_States#St._Louis#pharmaceuticals#Generic_Drugs#Par_Health
Par Health Emerges as Independent Leader in Generic Pharmaceuticals and Sterile Injectables
Par Health has successfully spun off from Mallinckrodt, establishing itself as a top U.S. player in generic drugs and sterile injectables, poised for growth.
third-news.com
November 10, 2025 at 11:56 AM
Par Health Emerges as Independent Leader in Generic Pharmaceuticals and Sterile Injectables#United_States#St._Louis#pharmaceuticals#Generic_Drugs#Par_Health
Class Action Settlement for Prescription Generic Drug Users in the U.S. Revealed#USA#Class_Action#Philadelphia#Settlement#Generic_Drugs
Class Action Settlement for Prescription Generic Drug Users in the U.S. Revealed
A significant legal notice details a class action settlement for individuals who paid for certain prescription generic drugs in the U.S. from May 2009 to December 2019.
third-news.com
October 3, 2025 at 10:12 PM
Class Action Settlement for Prescription Generic Drug Users in the U.S. Revealed#USA#Class_Action#Philadelphia#Settlement#Generic_Drugs
Fine, Kaplan and Black Announces Settlement in Class Action for Prescription Drug Payments#United_States#Class_Action#Philadelphia#Lawsuit#Generic_Drugs
Fine, Kaplan and Black Announces Settlement in Class Action for Prescription Drug Payments
Fine, Kaplan and Black, R.P.C. has announced a settlement in a class action lawsuit for those who incurred costs for certain prescription generic drugs between 2009 and 2019.
third-news.com
October 3, 2025 at 10:12 PM
Fine, Kaplan and Black Announces Settlement in Class Action for Prescription Drug Payments#United_States#Class_Action#Philadelphia#Lawsuit#Generic_Drugs
Class Action Settlement Announced for Prescription Generic Drugs in the USA#United_States#Class_Action#Philadelphia#Generic_Drugs#Antitrust_Laws
Class Action Settlement Announced for Prescription Generic Drugs in the USA
A federal court has authorized a $200 million class action settlement related to certain prescription generic drugs. Eligible individuals can make claims if they paid or reimbursed for these drugs in the U.S. between 2009 and 2019.
third-news.com
October 3, 2025 at 10:11 PM
Class Action Settlement Announced for Prescription Generic Drugs in the USA#United_States#Class_Action#Philadelphia#Generic_Drugs#Antitrust_Laws
Settlement Announcement for Class Action on Prescription Generic Drugs in the US#USA#Class_Action#Philadelphia#Settlement#Generic_Drugs
Settlement Announcement for Class Action on Prescription Generic Drugs in the US
A legal notice about a class action settlement available for individuals who paid for specific prescription generic drugs from 2009 to 2019 in the U.S.
third-news.com
October 3, 2025 at 10:11 PM
Settlement Announcement for Class Action on Prescription Generic Drugs in the US#USA#Class_Action#Philadelphia#Settlement#Generic_Drugs
NastLaw LLC and Plaintiffs Announce New Settlements in Antitrust Case Against Generic Pharmaceutical Pricing#USA#Philadelphia#Generic_Drugs#Antitrust#NastLaw
NastLaw LLC and Plaintiffs Announce New Settlements in Antitrust Case Against Generic Pharmaceutical Pricing
NastLaw LLC and Direct Purchaser Plaintiffs have announced proposed settlements in a significant antitrust case regarding pricing of generic pharmaceuticals, impacting many buyers.
third-news.com
September 11, 2025 at 2:13 PM
NastLaw LLC and Plaintiffs Announce New Settlements in Antitrust Case Against Generic Pharmaceutical Pricing#USA#Philadelphia#Generic_Drugs#Antitrust#NastLaw
Connecticut Attorney General Announces Settlement with Apotex for Inflating Generic Drug Prices#USA#Hartford#Generic_Drugs#Price-Fixing#Apotex_Corp
Connecticut Attorney General Announces Settlement with Apotex for Inflating Generic Drug Prices
Consumers who purchased certain generic drugs may be eligible for compensation due to a recent settlement with Apotex Corp., concerning price-fixing conspiracies.
third-news.com
June 9, 2025 at 12:12 PM
Connecticut Attorney General Announces Settlement with Apotex for Inflating Generic Drug Prices#USA#Hartford#Generic_Drugs#Price-Fixing#Apotex_Corp
Preliminary Settlement Approved with Apotex Corp for Price Manipulation in U.S. Prescription Market#United_States#Hartford#Generic_Drugs#Apotex_Corp#Price_Manipulation
Preliminary Settlement Approved with Apotex Corp for Price Manipulation in U.S. Prescription Market
Consumers who purchased specific generic prescription drugs between 2009 and 2019 may be eligible for compensation due to a settlement with Apotex Corp in price manipulation cases.
third-news.com
June 9, 2025 at 12:12 PM
Preliminary Settlement Approved with Apotex Corp for Price Manipulation in U.S. Prescription Market#United_States#Hartford#Generic_Drugs#Apotex_Corp#Price_Manipulation
Settlement Approved for Consumers Affected by Apotex's Price Manipulation of Generic Drugs#USA#Hartford#Generic_Drugs#Apotex_Corp#Price_Manipulation
Settlement Approved for Consumers Affected by Apotex's Price Manipulation of Generic Drugs
Consumers who purchased specific generic drugs between 2009 and 2019 may be eligible for compensation from a newly approved settlement with Apotex Corp.
third-news.com
June 9, 2025 at 12:12 PM
Settlement Approved for Consumers Affected by Apotex's Price Manipulation of Generic Drugs#USA#Hartford#Generic_Drugs#Apotex_Corp#Price_Manipulation
Settlement of $275 Million Class Action to Aid Consumers in Prescription Drug Prices#USA#Class_Action#Philadelphia#Health_Care#Generic_Drugs
Settlement of $275 Million Class Action to Aid Consumers in Prescription Drug Prices
A historic $275 million class action settlement has been announced, aimed at assisting consumers and third-party payers who overpaid for generic prescription drugs. Eligible parties can claim their share under court settlement.
third-news.com
March 10, 2025 at 7:07 PM
Settlement of $275 Million Class Action to Aid Consumers in Prescription Drug Prices#USA#Class_Action#Philadelphia#Health_Care#Generic_Drugs